SecBot SecBot
SC 13G ·Filed Nov 4, 2026

LENZ

LENZ Therapeutics, Inc.
NEUTRAL
Impact 4/10
Processed1h 27m ago SEC0001373604-26-000076
Passive investor 5%+ stake

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0001373604-26-000076
Document: 0001373604-26-000076-index.html0001373604-26-000076
Document: 0001373604-26-000076.txt0001373604-26-000076
14 reports for LENZ
Performance horizon
80% Hit rate @ T+1 4 of 5 bullish or bearish reports Went positive at some point 4 of 5 best @ T+1▲ +12.61%Oct 28, 2026
Filters
Rows
Reports for LENZ, sortable and filterable
TypeNow
Nov 4, 2026
today
SC 13G
NEUTRAL ★ 4/10
$3.46awaiting T+1awaiting T+1$3.46 (+0.00%)
Nov 2, 2026
1d ago
SC 13D/A
BEARISH ★ 6/10
$3.50 $3.46▲ +1.14%▲ +2.79%$3.46 (+1.14%)
Oct 28, 2026
7d ago
8-K
BEARISH ★ 6/10
No priceawaiting T+1awaiting T+1No price
Oct 28, 2026
7d ago
Press Release
BEARISH ★ 6/10
$3.49 $3.05▲ +12.61%▲ +10.83%$3.46 (+0.86%)
Oct 22, 2026
13d ago
Press Release
NEUTRAL ★ 1/10
$3.25awaiting T+1awaiting T+1$3.46 (+6.46%)
Oct 21, 2026
14d ago
SC 13G/A
NEUTRAL ★ 4/10
$3.25 $3.16▼ −2.77%▼ −2.25%$3.46 (+6.46%)
Aug 11, 2026
12w ago
Press Release
MIXED ★ 5/10
$5.04 $4.60▼ −8.73%▼ −9.43%$3.46 (−31.35%)
Jul 2, 2026
17w ago
8-K
NEUTRAL ★ 2/10
$5.89 $5.60▼ −4.92%▼ −5.80%$3.46 (−41.26%)
Jun 11, 2026
20w ago
Institutional Cluster
BULLISH ★ 6/10
$6.50 $6.77▲ +4.15%▲ +3.61%$3.46 (−46.77%)
Jun 7, 2026
21w ago
Press Release
BULLISH ★ 6/10
$6.72 $6.79▲ +1.04%▲ +1.34%$3.46 (−48.51%)
Showing 10 of 14

US Market Status

Market Closed · Opens Thu (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 4, 2026

Fresh LENZ Intelligence

Analysis is for subscribers only.

Subscribe for Full Access